GS vs NMR
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 17, 2026
GS
68.5
AI Score
VS
GS Wins
NMR
46.9
AI Score
Investment Advisor Scores
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | GS | NMR | Winner |
|---|---|---|---|
| Net Income | 12.26B | -368.00M | GS |
| ROE | 10.0% | -1.4% | GS |
| ROA | 0.6% | -0.1% | GS |
| Total Assets | 2.13T | 479.44B | GS |
| Cash | 187.27B | 7.16B | GS |
| Debt/Equity | 1.86 | 4.30 | GS |
| Free Cash Flow | -26.83B | -12.62B | NMR |
Relative Price Performance (Last 90 Days)
GS 1M: -2.7%
· 3M: +3.6%
NMR 1M: -0.7%
· 3M: +20.1%
Current Technical Phase
GS
NeutralHold
Mixed signals - no dominant trend phase, RSI 49
NMR
MarkupHold / add on dips
Price above SMA50, rising 50-day trend (6.7% over 20 days), RSI 53
Fundamentals Snapshot
| Metric | GS | NMR |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 14.0 | 13.0 |
| Trailing P/E | 15.5 | 11.4 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.4% | 0.3% |
| Gross Margin | 0.8% | 0.8% |
| Operating Margin | 0.4% | 0.3% |
| EPS | 64.77 | 0.83 |
| Dividend Yield | 0.02% | 0.03% |
Frequently Asked Questions
Based on our detailed analysis, GS is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.